Tag: CBT > Cannabis Schedule: Page 9

Adult-Use Legalization Bill

Congressional Committee Hearing Navigates the Catch-22 of Cannabis Research

The far-reaching committee hearing was convened to discuss six cannabis reform proposals currently undergoing congressional consideration.

January 17, 2020

Legislation and Regulation

Akers Bio Forms Advisory Board to Explore Involvement in the Hemp and Minor Cannabinoid Market

Recent FDA statements on the danger of CBD products in the open market and the need for DEA-regulated testing have given companies like Akers Bio an opportunity to explore a role in hemp and minor cannabinoid testing and processing.

December 6, 2019

Legislation and Regulation

Key House Committee Approves MORE Act to Federally Decriminalize Cannabis

The House Judiciary Committee approved the legislation in a bipartisan vote of 24 to 10, sending it for a floor vote.

November 20, 2019

Legislation and Regulation

House Judiciary Committee Sets Major Cannabis Vote on MORE Act

The MORE Act would decriminalize cannabis at the federal level by removing the plant from the Controlled Substances Act.

November 18, 2019

Legislation and Regulation

Senate Committee Hearing Emphasizes the Need for Policy Change to Increase Cannabis Research Access

This week, Senators Feinstein and Cornyn convened a panel of leading health experts to uncover the health impact of cannabis on consumers. Instead, they were hit with the realization that the only way to determine those impacts is through increased research access.

October 25, 2019